UMIN-ICDS History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000049997 |
|---|---|
| Receipt number | R000054531 |
| Scientific Title | An observational study to evaluate the safety and efficacy of lenvatinib plus pembrolizumab combination therapy for advanced or recurrent uterine cancer after use of platinum-based drugs(GOGO-EM4) |
| Date of disclosure of the study information | 2023/01/10 |
| Last modified on | 2023/01/11 06:16:56 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2023/01/10 11:01:23 | ||
| 2 | Update | 2023/01/11 06:06:25 | Public title Public title Acronym Acronym Scientific Title Scientific Title Scientific Title:Acronym Scientific Title:Acronym |
|
| 3 | Update | 2023/01/11 06:10:54 | Narrative objectives1 Trial characteristics_1 Trial characteristics_2 Developmental phase Key secondary outcomes Key secondary outcomes |
|
| 4 | Update | 2023/01/11 06:16:56 | Key inclusion criteria Key exclusion criteria |
